REMSLEEP HOLDINGS, INC. ENGAGES NEW REGULATORY AGENCY
Tampa, FL – (NewMediaWire) – June 1, 2021 – REMSleep
Holdings, Inc. (OTC: RMSL) (the “Company”) announces the company has engaged
Empirical Technologies Corp to complete its 510K process. Remsleep has
become frustrated with the progress of its 510K submission. Partnering
with ETC will ensure the Remsleep 510K submission will be streamlined and put
the company’s 510K submission on the right track. Remsleep plans to
engage ETC with all future regulatory needs. 510K submissions through ETC
have record of approval 20% to 40% faster than the industry average. ETC
has a 100% success rate with filing 510K’s, which gives the company confidence
with the submission.
Remsleep received patent
approval of its utility patent application April 2021.
The company is poised to launch
marketing program as soon as 510k clearance is complete. The company continues
to work on new product and expects to release future product with far greater
ease and timely manner.
Statements. This press release may contain forward-looking statements
regarding Company. All statements, other than statements of historical fact
included herein, are “forward-looking statements” including
statements regarding the Company’s future prospects and risks in investing in
Company’s common stock. These statements are based upon the Company’s current
expectations and speak only as of the date hereof. Financial performance in one
period does not necessarily mean continued or better performance in the future.
The Company’s actual results in any endeavor may differ materially and
adversely from those expressed in any forward-looking statements as a result of
various factors and uncertainties, which factors or uncertainties may be beyond
our ability to foresee or control. Other risk factors include the status of the
Company’s common stock as a “penny stock” and those risk factors
stated in reports filed with the U.S. Securities and Exchange Commission or
“SEC” on its EDGAR website (URL: www.sec.gov).